{"id":464428,"date":"2021-03-24T12:19:15","date_gmt":"2021-03-24T16:19:15","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=464428"},"modified":"2021-03-24T12:19:15","modified_gmt":"2021-03-24T16:19:15","slug":"aqst-deadline-zhang-investor-law-alerts-investors-of-deadline-in-securities-class-action-lawsuit-against-aquestive-therapeutics-inc-aqst-2","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/aqst-deadline-zhang-investor-law-alerts-investors-of-deadline-in-securities-class-action-lawsuit-against-aquestive-therapeutics-inc-aqst-2\/","title":{"rendered":"AQST DEADLINE: Zhang Investor Law Alerts Investors of Deadline in Securities Class Action Lawsuit Against Aquestive Therapeutics, Inc. \u2013 AQST"},"content":{"rendered":"<div class=\"mw_release\">\n<p>NEW YORK, March  24, 2021  (GLOBE NEWSWIRE) &#8212; Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of Aquestive Therapeutics, Inc. (NASDAQ: AQST) between December 2, 2019 and September 25, 2020, inclusive (the \u201cClass Period\u201d).<\/p>\n<p>To join the class action, go to <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=pHrJuiYrW4OO45hJ95auR5pam1frW48s9t7AVrElyN8xu0ekjh6wAdNukNVROmlIyOL2mGFyydbewAjT2cMH_3rBk0iJa1-RMe7mWMEONPVu2Sb7_KhVc-8FvUlsAv5ABdgZ_nQgWOOraIoNkQnFKxDqoSDn0cr0q3t0pvpSBtWVgcMeiBMglbr2SKme70fY_ZUG_268ePz2D0V_E_O2JJvmf8OUyRYDE-lYpG7PmYU33napGLk7OFOS9h1jZVLag_2hlPbEkhF05zEPePHwpw==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">http:\/\/zhanginvestorlaw.com\/join-action-form\/?slug=aquestive-therapeutics-inc&amp;id=2639<\/a> or call Sophie Zhang, Esq. toll-free at 800-991-3756 or email\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=2xdk0SSmSNnSg_sK5ibx6Nb-ixV-UgYl-Gx0liANqQTCH__FkptYuE2LlWge34isE1vrHhcQALrNpLMsYsbjqNLpSyEDfjexFyYJ8yl4vn0=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">info@zhanginvestorlaw.com<\/a>\u00a0for information on the class action.<\/p>\n<p>\u5982\u679c\u60a8\u60f3\u52a0\u5165\u8fd9\u4e2a\u96c6\u4f53\u8bc9\u8bbc\u6848\uff0c\u8bf7\u5728\u8fd9\u91cc\u63d0\u4ea4\u60a8\u7684\u4fe1\u606f\u3002<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=pHrJuiYrW4OO45hJ95auR5pam1frW48s9t7AVrElyN8xu0ekjh6wAdNukNVROmlIyOL2mGFyydbewAjT2cMH_3rBk0iJa1-RMe7mWMEONPVu2Sb7_KhVc-8FvUlsAv5AFl99s2safEzr7KS-6vQ4CiIDhB6D_c5X_WxeXOuNiqAylHd6ntKa_ht_XfjfeKyeRaAr7SCUDj2wyL_iYwBUPITyh8cJ0xnStrhiX1fYFcq_CtyS9LaJGV5-UysVl_q9O1PUgegV4_ihWhvTf3t7rQ==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">http:\/\/zhanginvestorlaw.com\/join-action-form\/?slug=aquestive-therapeutics-inc&amp;id=2639<\/a><\/p>\n<p>If you wish to serve as lead plaintiff, you must move the Court before the <strong>April 30, 2021 DEADLINE.<\/strong>\u00a0 A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.\u00a0<\/p>\n<p>According to the lawsuit, defendants throughout the Class Period made false and\/or misleading statements and\/or failed to disclose that- data included in the Libervant Buccal Film for the management of seizure clusters (\u201cLibervant\u201d) New Drug Application (\u201cNDA\u201d) submission showed a lower drug exposure level than desired for certain weight groups; the foregoing significantly decreased the Libervant NDA\u2019s approval prospects; as a result, it was foreseeable that the U.S. Food and Drug Administration (\u201cFDA\u201d) would not approve the Libervant NDA in its current form; and as a result, the Company\u2019s public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.<\/p>\n<p>Lead plaintiff status is not required to seek compensation.\u00a0 You may retain counsel of your choice.\u00a0 You may remain an absent class member and take no action at this time.<\/p>\n<p>Zhang Investor Law represents investors worldwide. Attorney Advertising. Prior results do not guarantee similar outcomes.<\/p>\n<p>Zhang Investor Law P.C.<br \/>99 Wall Street, Suite 232<br \/>New York, New York 10005<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=2xdk0SSmSNnSg_sK5ibx6Nb-ixV-UgYl-Gx0liANqQQXYzdSGuz6j0XxoDm79d0Jryjy4h6wYKEhSpcYaMY9CPEml2XgNQvnit5ilKmWviA=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">info@zhanginvestorlaw.com<\/a><br \/>tel: (800) 991-3756<\/p>\n<p \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIwNTg0MCM0MDkwMTE0IzUwMDA1MzY0MQ==\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/6faf531a-ce73-49fb-bc43-fd5d9daeb611\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>NEW YORK, March 24, 2021 (GLOBE NEWSWIRE) &#8212; Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of Aquestive Therapeutics, Inc. (NASDAQ: AQST) between December 2, 2019 and September 25, 2020, inclusive (the \u201cClass Period\u201d). To join the class action, go to http:\/\/zhanginvestorlaw.com\/join-action-form\/?slug=aquestive-therapeutics-inc&amp;id=2639 or call Sophie Zhang, Esq. toll-free at 800-991-3756 or email\u00a0info@zhanginvestorlaw.com\u00a0for information on the class action. \u5982\u679c\u60a8\u60f3\u52a0\u5165\u8fd9\u4e2a\u96c6\u4f53\u8bc9\u8bbc\u6848\uff0c\u8bf7\u5728\u8fd9\u91cc\u63d0\u4ea4\u60a8\u7684\u4fe1\u606f\u3002http:\/\/zhanginvestorlaw.com\/join-action-form\/?slug=aquestive-therapeutics-inc&amp;id=2639 If you wish to serve as lead plaintiff, you must move the Court before the April 30, 2021 DEADLINE.\u00a0 A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.\u00a0 According to the lawsuit, defendants throughout the Class Period made false and\/or misleading statements and\/or failed to disclose &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/aqst-deadline-zhang-investor-law-alerts-investors-of-deadline-in-securities-class-action-lawsuit-against-aquestive-therapeutics-inc-aqst-2\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;AQST DEADLINE: Zhang Investor Law Alerts Investors of Deadline in Securities Class Action Lawsuit Against Aquestive Therapeutics, Inc. \u2013 AQST&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-464428","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>AQST DEADLINE: Zhang Investor Law Alerts Investors of Deadline in Securities Class Action Lawsuit Against Aquestive Therapeutics, Inc. \u2013 AQST - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/aqst-deadline-zhang-investor-law-alerts-investors-of-deadline-in-securities-class-action-lawsuit-against-aquestive-therapeutics-inc-aqst-2\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"AQST DEADLINE: Zhang Investor Law Alerts Investors of Deadline in Securities Class Action Lawsuit Against Aquestive Therapeutics, Inc. \u2013 AQST - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEW YORK, March 24, 2021 (GLOBE NEWSWIRE) &#8212; Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of Aquestive Therapeutics, Inc. (NASDAQ: AQST) between December 2, 2019 and September 25, 2020, inclusive (the \u201cClass Period\u201d). To join the class action, go to http:\/\/zhanginvestorlaw.com\/join-action-form\/?slug=aquestive-therapeutics-inc&amp;id=2639 or call Sophie Zhang, Esq. toll-free at 800-991-3756 or email\u00a0info@zhanginvestorlaw.com\u00a0for information on the class action. \u5982\u679c\u60a8\u60f3\u52a0\u5165\u8fd9\u4e2a\u96c6\u4f53\u8bc9\u8bbc\u6848\uff0c\u8bf7\u5728\u8fd9\u91cc\u63d0\u4ea4\u60a8\u7684\u4fe1\u606f\u3002http:\/\/zhanginvestorlaw.com\/join-action-form\/?slug=aquestive-therapeutics-inc&amp;id=2639 If you wish to serve as lead plaintiff, you must move the Court before the April 30, 2021 DEADLINE.\u00a0 A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.\u00a0 According to the lawsuit, defendants throughout the Class Period made false and\/or misleading statements and\/or failed to disclose &hellip; Continue reading &quot;AQST DEADLINE: Zhang Investor Law Alerts Investors of Deadline in Securities Class Action Lawsuit Against Aquestive Therapeutics, Inc. \u2013 AQST&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/aqst-deadline-zhang-investor-law-alerts-investors-of-deadline-in-securities-class-action-lawsuit-against-aquestive-therapeutics-inc-aqst-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-03-24T16:19:15+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIwNTg0MCM0MDkwMTE0IzUwMDA1MzY0MQ==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aqst-deadline-zhang-investor-law-alerts-investors-of-deadline-in-securities-class-action-lawsuit-against-aquestive-therapeutics-inc-aqst-2\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aqst-deadline-zhang-investor-law-alerts-investors-of-deadline-in-securities-class-action-lawsuit-against-aquestive-therapeutics-inc-aqst-2\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"AQST DEADLINE: Zhang Investor Law Alerts Investors of Deadline in Securities Class Action Lawsuit Against Aquestive Therapeutics, Inc. \u2013 AQST\",\"datePublished\":\"2021-03-24T16:19:15+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aqst-deadline-zhang-investor-law-alerts-investors-of-deadline-in-securities-class-action-lawsuit-against-aquestive-therapeutics-inc-aqst-2\\\/\"},\"wordCount\":313,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aqst-deadline-zhang-investor-law-alerts-investors-of-deadline-in-securities-class-action-lawsuit-against-aquestive-therapeutics-inc-aqst-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIwNTg0MCM0MDkwMTE0IzUwMDA1MzY0MQ==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aqst-deadline-zhang-investor-law-alerts-investors-of-deadline-in-securities-class-action-lawsuit-against-aquestive-therapeutics-inc-aqst-2\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aqst-deadline-zhang-investor-law-alerts-investors-of-deadline-in-securities-class-action-lawsuit-against-aquestive-therapeutics-inc-aqst-2\\\/\",\"name\":\"AQST DEADLINE: Zhang Investor Law Alerts Investors of Deadline in Securities Class Action Lawsuit Against Aquestive Therapeutics, Inc. \u2013 AQST - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aqst-deadline-zhang-investor-law-alerts-investors-of-deadline-in-securities-class-action-lawsuit-against-aquestive-therapeutics-inc-aqst-2\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aqst-deadline-zhang-investor-law-alerts-investors-of-deadline-in-securities-class-action-lawsuit-against-aquestive-therapeutics-inc-aqst-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIwNTg0MCM0MDkwMTE0IzUwMDA1MzY0MQ==\",\"datePublished\":\"2021-03-24T16:19:15+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aqst-deadline-zhang-investor-law-alerts-investors-of-deadline-in-securities-class-action-lawsuit-against-aquestive-therapeutics-inc-aqst-2\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aqst-deadline-zhang-investor-law-alerts-investors-of-deadline-in-securities-class-action-lawsuit-against-aquestive-therapeutics-inc-aqst-2\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aqst-deadline-zhang-investor-law-alerts-investors-of-deadline-in-securities-class-action-lawsuit-against-aquestive-therapeutics-inc-aqst-2\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIwNTg0MCM0MDkwMTE0IzUwMDA1MzY0MQ==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIwNTg0MCM0MDkwMTE0IzUwMDA1MzY0MQ==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aqst-deadline-zhang-investor-law-alerts-investors-of-deadline-in-securities-class-action-lawsuit-against-aquestive-therapeutics-inc-aqst-2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"AQST DEADLINE: Zhang Investor Law Alerts Investors of Deadline in Securities Class Action Lawsuit Against Aquestive Therapeutics, Inc. \u2013 AQST\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"AQST DEADLINE: Zhang Investor Law Alerts Investors of Deadline in Securities Class Action Lawsuit Against Aquestive Therapeutics, Inc. \u2013 AQST - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/aqst-deadline-zhang-investor-law-alerts-investors-of-deadline-in-securities-class-action-lawsuit-against-aquestive-therapeutics-inc-aqst-2\/","og_locale":"en_US","og_type":"article","og_title":"AQST DEADLINE: Zhang Investor Law Alerts Investors of Deadline in Securities Class Action Lawsuit Against Aquestive Therapeutics, Inc. \u2013 AQST - Market Newsdesk","og_description":"NEW YORK, March 24, 2021 (GLOBE NEWSWIRE) &#8212; Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of Aquestive Therapeutics, Inc. (NASDAQ: AQST) between December 2, 2019 and September 25, 2020, inclusive (the \u201cClass Period\u201d). To join the class action, go to http:\/\/zhanginvestorlaw.com\/join-action-form\/?slug=aquestive-therapeutics-inc&amp;id=2639 or call Sophie Zhang, Esq. toll-free at 800-991-3756 or email\u00a0info@zhanginvestorlaw.com\u00a0for information on the class action. \u5982\u679c\u60a8\u60f3\u52a0\u5165\u8fd9\u4e2a\u96c6\u4f53\u8bc9\u8bbc\u6848\uff0c\u8bf7\u5728\u8fd9\u91cc\u63d0\u4ea4\u60a8\u7684\u4fe1\u606f\u3002http:\/\/zhanginvestorlaw.com\/join-action-form\/?slug=aquestive-therapeutics-inc&amp;id=2639 If you wish to serve as lead plaintiff, you must move the Court before the April 30, 2021 DEADLINE.\u00a0 A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.\u00a0 According to the lawsuit, defendants throughout the Class Period made false and\/or misleading statements and\/or failed to disclose &hellip; Continue reading \"AQST DEADLINE: Zhang Investor Law Alerts Investors of Deadline in Securities Class Action Lawsuit Against Aquestive Therapeutics, Inc. \u2013 AQST\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/aqst-deadline-zhang-investor-law-alerts-investors-of-deadline-in-securities-class-action-lawsuit-against-aquestive-therapeutics-inc-aqst-2\/","og_site_name":"Market Newsdesk","article_published_time":"2021-03-24T16:19:15+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIwNTg0MCM0MDkwMTE0IzUwMDA1MzY0MQ==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aqst-deadline-zhang-investor-law-alerts-investors-of-deadline-in-securities-class-action-lawsuit-against-aquestive-therapeutics-inc-aqst-2\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aqst-deadline-zhang-investor-law-alerts-investors-of-deadline-in-securities-class-action-lawsuit-against-aquestive-therapeutics-inc-aqst-2\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"AQST DEADLINE: Zhang Investor Law Alerts Investors of Deadline in Securities Class Action Lawsuit Against Aquestive Therapeutics, Inc. \u2013 AQST","datePublished":"2021-03-24T16:19:15+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aqst-deadline-zhang-investor-law-alerts-investors-of-deadline-in-securities-class-action-lawsuit-against-aquestive-therapeutics-inc-aqst-2\/"},"wordCount":313,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aqst-deadline-zhang-investor-law-alerts-investors-of-deadline-in-securities-class-action-lawsuit-against-aquestive-therapeutics-inc-aqst-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIwNTg0MCM0MDkwMTE0IzUwMDA1MzY0MQ==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aqst-deadline-zhang-investor-law-alerts-investors-of-deadline-in-securities-class-action-lawsuit-against-aquestive-therapeutics-inc-aqst-2\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/aqst-deadline-zhang-investor-law-alerts-investors-of-deadline-in-securities-class-action-lawsuit-against-aquestive-therapeutics-inc-aqst-2\/","name":"AQST DEADLINE: Zhang Investor Law Alerts Investors of Deadline in Securities Class Action Lawsuit Against Aquestive Therapeutics, Inc. \u2013 AQST - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aqst-deadline-zhang-investor-law-alerts-investors-of-deadline-in-securities-class-action-lawsuit-against-aquestive-therapeutics-inc-aqst-2\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aqst-deadline-zhang-investor-law-alerts-investors-of-deadline-in-securities-class-action-lawsuit-against-aquestive-therapeutics-inc-aqst-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIwNTg0MCM0MDkwMTE0IzUwMDA1MzY0MQ==","datePublished":"2021-03-24T16:19:15+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aqst-deadline-zhang-investor-law-alerts-investors-of-deadline-in-securities-class-action-lawsuit-against-aquestive-therapeutics-inc-aqst-2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/aqst-deadline-zhang-investor-law-alerts-investors-of-deadline-in-securities-class-action-lawsuit-against-aquestive-therapeutics-inc-aqst-2\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aqst-deadline-zhang-investor-law-alerts-investors-of-deadline-in-securities-class-action-lawsuit-against-aquestive-therapeutics-inc-aqst-2\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIwNTg0MCM0MDkwMTE0IzUwMDA1MzY0MQ==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIwNTg0MCM0MDkwMTE0IzUwMDA1MzY0MQ=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aqst-deadline-zhang-investor-law-alerts-investors-of-deadline-in-securities-class-action-lawsuit-against-aquestive-therapeutics-inc-aqst-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"AQST DEADLINE: Zhang Investor Law Alerts Investors of Deadline in Securities Class Action Lawsuit Against Aquestive Therapeutics, Inc. \u2013 AQST"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/464428","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=464428"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/464428\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=464428"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=464428"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=464428"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}